Mio Yano

522 total citations
12 papers, 176 citations indexed

About

Mio Yano is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Molecular Biology. According to data from OpenAlex, Mio Yano has authored 12 papers receiving a total of 176 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 10 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in Mio Yano's work include Acute Lymphoblastic Leukemia research (9 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Acute Myeloid Leukemia Research (5 papers). Mio Yano is often cited by papers focused on Acute Lymphoblastic Leukemia research (9 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Acute Myeloid Leukemia Research (5 papers). Mio Yano collaborates with scholars based in Japan and Hong Kong. Mio Yano's co-authors include Toshihiko Imamura, Hajime Hosoi, Hideki Yoshida, Kenichi Sakamoto, Takeshi Okubo, Yusuke Tomita, Olga E. Khokhlova, Hirokazu Isobe, Yasuhiro Shibuya and Pak‐Leung Ho and has published in prestigious journals such as Blood, PLoS ONE and British Journal of Haematology.

In The Last Decade

Mio Yano

11 papers receiving 175 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mio Yano Japan 6 92 78 69 58 35 12 176
Caitlin W. Elgarten United States 7 68 0.7× 34 0.4× 24 0.3× 91 1.6× 4 0.1× 37 207
Jowita Frączkiewicz Poland 8 44 0.5× 26 0.3× 17 0.2× 60 1.0× 8 0.2× 34 185
Jean Hugues Dalle France 6 38 0.4× 61 0.8× 27 0.4× 108 1.9× 2 0.1× 9 198
Veronica Gonzalez-Pena United States 4 96 1.0× 12 0.2× 18 0.3× 10 0.2× 40 1.1× 9 190
Eva Heredero Gálvez Spain 6 17 0.2× 27 0.3× 16 0.2× 70 1.2× 9 0.3× 18 140
Hélène Labussière‐Wallet France 7 19 0.2× 42 0.5× 16 0.2× 130 2.2× 4 0.1× 20 170
Divya Koura United States 6 26 0.3× 18 0.2× 9 0.1× 46 0.8× 6 0.2× 18 105
Anne C. Wilke Germany 6 15 0.2× 41 0.5× 8 0.1× 44 0.8× 8 0.2× 7 119
Ceri Bygrave United Kingdom 6 69 0.8× 12 0.2× 73 1.1× 77 1.3× 3 0.1× 18 167
Céline Baulard France 5 58 0.6× 26 0.3× 52 0.8× 63 1.1× 1 0.0× 5 199

Countries citing papers authored by Mio Yano

Since Specialization
Citations

This map shows the geographic impact of Mio Yano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mio Yano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mio Yano more than expected).

Fields of papers citing papers by Mio Yano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mio Yano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mio Yano. The network helps show where Mio Yano may publish in the future.

Co-authorship network of co-authors of Mio Yano

This figure shows the co-authorship network connecting the top 25 collaborators of Mio Yano. A scholar is included among the top collaborators of Mio Yano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mio Yano. Mio Yano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Ishida, Hisashi, Mio Yano, Daiichiro Hasegawa, et al.. (2021). Prednisolone poor response is not an indication for HSCT in pediatric B-cell precursor acute lymphoblastic leukemia in first remission: results from JACLS ALL-02 study. International Journal of Hematology. 113(6). 893–902.
2.
Imamura, Toshihiko, Kuniaki Tanaka, Itaru Kato, et al.. (2020). Leukemic cells expressing NCOR1-LYN are sensitive to dasatinib in vivo in a patient-derived xenograft mouse model. Leukemia. 35(7). 2092–2096. 4 indexed citations
3.
Imamura, Toshihiko, Mio Yano, Daisuke Asai, et al.. (2018). Copy number abnormality of acute lymphoblastic leukemia cell lines based on their genetic subtypes. International Journal of Hematology. 108(3). 312–318. 11 indexed citations
4.
Imamura, Toshihiko, Mio Yano, Kenichi Sakamoto, et al.. (2018). Leukemic Cell Expressing a Novel Kinase Fusion Protein NCOR1-LYN Exhibits High Sensitivity to Dasatinib and Rapamycin. Blood. 132(Supplement 1). 1557–1557. 1 indexed citations
5.
Yano, Mio, Toshihiko Imamura, Daisuke Asai, et al.. (2017). Clinical significance of SH2B3 (LNK) expression in paediatric B‐cell precursor acute lymphoblastic leukaemia. British Journal of Haematology. 183(2). 327–330. 4 indexed citations
6.
Sakamoto, Kenichi, Toshihiko Imamura, Mio Yano, et al.. (2016). Ph‐like acute lymphoblastic leukemia with a novel PAX5‐KIDINS220 fusion transcript. Genes Chromosomes and Cancer. 56(4). 278–284. 9 indexed citations
7.
Sakamoto, Kenichi, Seiji Tanaka, Mio Yano, et al.. (2016). Development of acute lymphoblastic leukemia with IgH-EPOR in a patient with secondary erythrocytosis. International Journal of Hematology. 104(6). 741–743. 2 indexed citations
8.
Imamura, Toshihiko, Mio Yano, Hideki Yoshida, et al.. (2015). BCL2 Inhibitor (ABT-737): A Restorer of Prednisolone Sensitivity in Early T-Cell Precursor-Acute Lymphoblastic Leukemia with High MEF2C Expression?. PLoS ONE. 10(7). e0132926–e0132926. 21 indexed citations
9.
Iwao, Yasuhisa, Yusuke Tomita, Yasuhiro Shibuya, et al.. (2015). The emerging ST8 methicillin-resistant Staphylococcus aureus clone in the community in Japan: associated infections, genetic diversity, and comparative genomics.. PubMed. Suppl 13. 15–27. 2 indexed citations
10.
Yano, Mio, Toshihiko Imamura, Daisuke Asai, et al.. (2014). An overall characterization of pediatric acute lymphoblastic leukemia with CRLF2 overexpression. Genes Chromosomes and Cancer. 53(10). 815–823. 25 indexed citations
11.
Sakamoto, Kenichi, Toshihiko Imamura, Mio Yano, et al.. (2014). Sensitivity of MLL-rearranged AML cells to all-trans retinoic acid is associated with the level of H3K4me2 in the RARα promoter region. Blood Cancer Journal. 4(4). e205–e205. 29 indexed citations
12.
Iwao, Yasuhisa, Tomomi Takano, Wei‐Chun Hung, et al.. (2012). The emerging ST8 methicillin-resistant Staphylococcus aureus clone in the community in Japan: associated infections, genetic diversity, and comparative genomics. Journal of Infection and Chemotherapy. 18(2). 228–240. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caitlin W. Elgarten Breakdown of academic impact, for papers by Jowita Frączkiewicz Breakdown of academic impact, for papers by Jean Hugues Dalle Breakdown of academic impact, for papers by Veronica Gonzalez-Pena Breakdown of academic impact, for papers by Eva Heredero Gálvez Breakdown of academic impact, for papers by Hélène Labussière‐Wallet Breakdown of academic impact, for papers by Divya Koura Breakdown of academic impact, for papers by Anne C. Wilke Breakdown of academic impact, for papers by Ceri Bygrave Breakdown of academic impact, for papers by Céline Baulard
Rankless by CCL
2026